U.S. Senate reauthorizes FDA to collect fees from drugmakers
Read More
Bagikan Berita Ini
Kamis, 03 Agustus 2017
News Business
U.S. Senate reauthorizes FDA to collect fees from drugmakers
(Reuters) - The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications.
U.S. Senate reauthorizes FDA to collect fees from drugmakers
Read More
Bagikan Berita Ini
U.S. Senate reauthorizes FDA to collect fees from drugmakers
Read More
Bagikan Berita Ini
0 Response to "U.S. Senate reauthorizes FDA to collect fees from drugmakers"
Posting Komentar